Path to Commercialization and Reimbursement
Even at the earliest stages of development, life science innovators need to understand and communicate a commercialization and pricing/reimbursement strategy. Your path to commercialization and reimbursement story is important to your investors, potential strategic partners and can influence your development plan.
Speaker: Aaron David, Jupiter Life Science Consulting
Jupiter partner Aaron Davis built the majority of his industry experience at Amylin Pharmaceuticals and Vertex Pharmaceuticals, launching first-in-class products before moving into managed markets consulting.
Building on his industry experience, Aaron has spent the last eight years in consulting, with a focus on pricing and reimbursement. His corporate, field and consulting experience is a unique combination in consulting. He provides Jupiter’s clients with the high level of strategic commercialization considerations and actionable insights.
Aaron has worked with many early stage biotech and device firms to understand their market, product value and how to communicate to investors and strategic partners.